Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

@article{Minotti2004AnthracyclinesMA,
  title={Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity},
  author={G. Minotti and P. Menna and E. Salvatorelli and G. Cairo and L. Gianni},
  journal={Pharmacological Reviews},
  year={2004},
  volume={56},
  pages={185 - 229}
}
The clinical use of anthracyclines like doxorubicin and daunorubicin can be viewed as a sort of double-edged sword. On the one hand, anthracyclines play an undisputed key role in the treatment of many neoplastic diseases; on the other hand, chronic administration of anthracyclines induces cardiomyopathy and congestive heart failure usually refractory to common medications. Second-generation analogs like epirubicin or idarubicin exhibit improvements in their therapeutic index, but the risk of… Expand
Role of anthracyclines in the era of targeted therapy
New developments in anthracycline-induced cardiotoxicity.
Anthracycline-induced cardiac toxicity: A clinical review
Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity.
Complications of chemotherapy, a basic science update.
Anthracyclines and mitochondria.
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy.
Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 419 REFERENCES
Cardiac toxicity of antineoplastic anthracyclines.
  • R. Zucchi, R. Danesi
  • Chemistry, Medicine
  • Current medicinal chemistry. Anti-cancer agents
  • 2003
The anthracyclines: will we ever find a better doxorubicin?
  • R. Weiss
  • Medicine
  • Seminars in oncology
  • 1992
Anthracycline drug targeting: cytoplasmic versus nuclear--a fork in the road.
Recent developments in the field of antitumour anthracyclines.
  • C. Monneret
  • Medicine
  • European journal of medicinal chemistry
  • 2001
Role of iron in anthracycline cardiotoxicity: new tunes for an old song?
  • G. Minotti, G. Cairo, E. Monti
  • Chemistry, Medicine
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 1999
Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines.
Doxorubicin cardiotoxicity: analysis of prevailing hypotheses
  • R. Olson, P. Mushlin
  • Medicine
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 1990
Pharmacokinetic-Pharmacodynamic Relationships of the Anthracycline Anticancer Drugs
Idarubicin: a brief overview on pharmacology and clinical use.
...
1
2
3
4
5
...